安五脂素
安五脂素 性质
| 熔点 | 70-71℃ |
|---|---|
| 沸点 | 467.0±40.0 °C(Predicted) |
| 密度 | 1.159 |
| 闪点 | 236℃ |
| 储存条件 | Store at -20°C |
| 溶解度 | 二甲基亚砜：≥30mg/mL（91.35mM） |
| 酸度系数(pKa) | 10.19±0.20(Predicted) |
| 形态 | 粉末 |
| 颜色 | 白色 |
| LogP | 5.220 (est) |
安五脂素 用途与合成方法
|
COX-2
|
Macelignan (1-50 μM; 72 hours) does not reduce cell viability alone, however, UVB treatment, even at the lowest dose of 30 mJ/cm 2 , reduces HaCaT cell viability in a dose-dependent mannner,it reduces approximately 80% of control values at 100 μM in hacat cells.Macelignan (0.1-1 μM; 24 hours) decreases COX-2 expression in a concentration-dependent manner,and at the highest concentration of macelignan (1 μM) , COX-2 expression is inhibited by almost 50% in hacat cells.
Cell Viability Assay
| Cell Line: | Hacat cells |
| Concentration: | 1 μM; 2.5 μM; 5 μM; 10 μM; 15 μM; 50 μM |
| Incubation Time: | 72 hours |
| Result: | Induced cell death by UVB irradiation at 30 mJ/cm 2 from 10 μM. |
Western Blot Analysis
| Cell Line: | Hacat cells |
| Concentration: | 0.1 μM; 0.5 μM;1 μM |
| Incubation Time: | 24 hours |
| Result: | Reduced UVB-induced COX-2 expression in cells. |
Macelignan (oral administration; 15 mg/kg; every day for three weeks) exhibits in vivo anti-diabetic effects. The baseline (day 0) fasting blood glucose levels does not differ between groups; at the end of the experiment, the values of the Macelignan-treated group are significantly lower compared to the diabetic control group in C57BL/KsJ- db/db mice.
| Animal Model: | Male C57BL/KsJ- db/db mice |
| Dosage: | 15 mg/kg |
| Administration: | Oral administration; 15 mg/kg; every day for three weeks |
| Result: | Significantly reduced the blood glucose levels in mice. |
药理药效:抗肿瘤、凝血
安五脂素 价格(试剂级)
| 更新日期 | 产品编号 | 产品名称 | CAS号 | 包装 | 价格 |
|---|---|---|---|---|---|
| 2024-11-08 | HY-N0064 | 1 mg | 350 | ||
| 2024-11-08 | HY-N0064 | 安五脂素 | 107534-93-0 | 5mg | 700 |
